A GWAS of the progression of abdominal aortic aneurysms and simultaneous use of genetic and non-genetic information in the evaluation of screening and diagnostic testing pathways (360G-Wellcome-222959_Z_21_Z)
In the UK, men aged 65 are invited to screening to check for an Abdominal Aortic Aneurysm (AAA). Untreated aneurysms may rupture, which is usually fatal, although many aneurysms do not progress to this stage. There are known risk factors for AAA such as smoking and family history. Evidence of genetic association with AAA has been found which means that some people are more at risk from birth of having an aneurysm. I plan to investigate the role of genetics in both the presence and progression of disease, utilising data from UKBiobank, the UK Aneurysm Growth Study and AAA-Express. These findings will be adopted into a hypothetical computer model. I will investigate the possibility of targeted screening for AAA. This involves identification of risk factors that will also consider the benefit of genetic data to identify individuals at high risk of AAA for screening invitation. I will then investigate an adapted clinical pathway after detection of aneurysm based on the risk of rupture. Incorporating genetic information may improve patient outcomes and the cost-effectiveness of the screening program by limiting screening to those most at risk and by ensuring that those diagnosed with an aneurysm have the most appropriate clinical intervention.
Where is this data from?
This data was originally published by The Wellcome Trust. If you see something about your organisation or the funding it has received on this page that doesn't look right you can submit a grantee amendment request. You can hover over codes from standard codelists to see the user-friendly name provided by 360Giving.